ABSTRACT Continuous measurements of transcutaneous oxygen tension (tcPo2) were made in 23 patients with radiological evidence of emphysema, at rest and during a maximal progressive exercise test. tcPo2 during the final phase of exercise was compared with tcPo2 at rest; the mean change (exercising minus resting value) in tcPo2 (AtcPo2) was -0-8 mm Hg (SD 10O5, range -18 to +25) (-0.1 kPa (SD 1-4, range -2-4 to +3-3)). AtcPo2 was correlated with: resting arterial oxygen tension (Pao2) (r = 0-606, p < 0.005); resting arterial carbon dioxide tension (Paco2) (r = -0-691, p < 0.001); FEV, % predicted (r = 0-688, p < 0.001); vital capacity % predicted (r = 0-543, p < 0-01); and transfer factor (TLco) % predicted (r = 0-604, p < 0-005). There was no significant difference between the AtcPo2 of 10 patients who regularly produced sputum and of 13 patients with no sputum. AtcPo2 appears to be more closely related to the severity of emphysema than to the presence or absence of chronic bronchitis. Pretreatment with fenoterol aerosol resulted in an increased work load in three out of 10 patients. Overall there was no change in AtcPo2. In all except one patient there was a rise in tcPo2 after the end of exercise. In the 11 patients whose tcPo2 fell during exercise, tcPo2 returned to the resting value within two minutes of the cessation of exercise; this was followed by a further rise beyond the resting value, and a single postexercise arterial sample is therefore a poor indicator of the response of Pao2 to exercise. Measurement of tcPo2 is of value in following rapid changes in Pao2 during and after exercise and avoids the necessity for an indwelling arterial cannula.
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Changes in arterial oxygen tension (Pao2) during exercise in patients with chronic airflow obstruction were reported by Jones,' who showed that patients with emphysema tended to develop further hypoxaemia during exercise whereas there was a rise in Pao2 in patients who had a similar degree of airflow obstruction but no emphysema. There has subsequently been much discussion of the possible physiological mechanisms underlying these findings. We have therefore carried out a similar study of the exercise induced blood gas changes in patients with emphysema of a wide range of severity with and without chronic bronchitis.
Inhaled bronchodilator agents have been shown to produce appreciable improvement in vital capacity in emphysematous patients at rest,23 though the improvement in exercise capacity is relatively small.4
In this study we have taken advantage of the opportunity to investigate the effects of the f2 adrenergic agent fenoterol on exercise induced changes in blood gases.
During exercise Pao2 is commonly monitored by intermittent direct sampling from an arterial cannula or indirectly on the basis of capillary samples from the warmed earlobe. Non-invasive monitoring techniques include the ear oximeter for the estimation of arterial oxygen saturation and the transcutaneous oxygen electrode, which we have used in this study.
The transcutaneous oxygen electrode5 6 is applied directly to the skin surface and incorporates a thermostatically controlled heater designed to promote dilatation and arterialisation of the local capillary circulation. The method has been used predominantly in the intensive care of newborn infants,78 where it gives reliable results, and it has been shown9 '0 to provide a good estimate of Pao2 in adult patients. A close relationship between transcutaneous oxygen tension (tcPo2) and Pao2 has been Changes in transcutaneous oxygen tension during exercise in pulmonary emphysema shown" in normal adults and in children with chronic lung disease, and a further objective of this study was to ascertain whether measurement of tcPo2 is of value in the assessment of blood gas changes during exercise in adults with chronic airflow obstruction.
Methods
Twenty three men with radiological evidence of pulmonary emphysema '2 '4 Transcutaneous oxygen tension was measured by the polarographic method by means of a platinum electrode (Dragerwerk, Lubeck, West Germany) heated to 45°C and applied to the skin surface over the biceps muscle; the design of the electrode is similar to that described by Huch et al.5 The output of the electrode could be read digitally or displayed on a chart recorder. Details of the calibration procedure are given at the end of this section.
A progressive exercise test was performed on an electrically braked cycle ergometer. The tcPo2 was monitored for at least one minute while the patient was seated at rest on the cycle ergometer, until a constant reading was obtained (tcPo2: rest) and was monitored throughout the exercise study and for 30 minutes after the end of exercise. tcPo2 was noted at the instant the patient stopped exercise (tcPo2: end ex) and when it reached the highest value during the postexercise period (tcPo2: post ex). The tcPo2 values at these specific points were read from the digital meter.
During the first minute of exercise no additional work load was applied; thereafter the load was increased by 10 watts every minute until the maximum load was attained. The electrocardiogram was displayed throughout the procedure but no dysrhythmic or ischaemic episodes were observed. Ten patients included in study 1 received two puffs from a placebo aerosol 30 minutes before the start of exercise as a preliminary to study 2. STUDY 2 Ten patients who had performed study 1 took part in a single blind study to compare the effects of fenoterol and placebo aerosols on tcPo2 during exercise. In these patients the placebo aerosol was administered as part of study 1. Forty five minutes after the end of study 1, FEV, and VC were measured before and 30 minutes after two puffs (400 ,g) from a fenoterol metered dose aerosol canister. The progressive exercise test was then repeated, tcPo2 being monitored at rest and during exercise as in study 1. The electrode remained in place throughout both studies. The drift was never more than 5% in any study and in most it was substantially less; the measurements were therefore not corrected for drift.
CALIBRATION OF tcPo2 ELECTRODE
Before each study the electrode was calibrated in vitro at two points, sodium sulphite solution (zero oxygen tension) and atmospheric air being used. 9 The electrode was then attached to the patient and after an interval of not less than 30 minutes (by which time a steady tcPo2 reading had been obtained) an arterial blood sample was taken by brachial or radial puncture. Arterial carbon dioxide tension (Paco2) and Pao2 were measured immediately (Dow-Coming analyser, type 165). The gain control of the tcPo2 system was then altered so that the output corresponded to the measured Pao2; we have called this procedure in vivo calibration. At the end of the study, the in vitro calibration against atmospheric air was repeated and shown to correspond to the initial value, after allowance had been made for any alteration in gain control necessitated by the in vivo calibration procedure.
We have shown'0 by simultaneous measurement of Pao2 and tcPo2 in 14 patients that this in vivo calibration procedure considerably improves the accuracy of tcPo2 measurement. For 55 data points over the range 50-120 mm Hg we obtained the relationship tcPo2 (mm Hg) = 0-98 Pao2 + 1-61 (95% confidence limits + 6-6 mm Hg).
An example of the close relationship between Pao2 and tcPo2 is shown in figure 1 ; during the postexercise rise in arterial Po2 the response of the tcPo2 electrode was complete within two minutes. The above regression equation and the results illustrated in figure 1 were obtained with the Radiometer electrode rather than the Drager electrode used for the main part of this study, but we and others'5 16 have found that they have similar characteristics. Results similar to those shown in figure 1 have been obtained in a further five patients studied in this laboratory. '7 The significance of differences between groups was assessed by means of a paired or unpaired Student's t test as appropriate. With the exception of one patient in group A, all patients showed a rise in tcPo2 after exercise (table 2). The mean difference between tcPo2 at the end of the exercise and tcPo2 at the peak of the postexercise rise was 18-8 mm Hg in group A and 19-7 mm Hg in group B; there was no significant difference between the two groups. The average interval between the end of the exercise and the maximum postexercise tcPo2 was 4½/2 minutes (range 3-6/2 minutes). Thirty minutes after the end of exercise the mean tcPo2 was still significantly above the initial resting value. The change in tcPo2 during exercise (AtcPo2), defined as tcPo2: end ex minus tcPo2: rest, was found to be significantly correlated with the arterial blood gas tensions and most lung function indices (table 3) when data from both groups were considered together. There was, however, no significant correlation between AtcPo2 and TLC. would be expected to demonstrate changes in Pao2 or tcPo2 more readily than submaximal tests.
Early interest in the physiological reasons for the exercise induced changes in Pao2 centred around the differing responses seen in the "emphysematous" and "chronic bronchitic" types of patient. Jones' postulated that in the bronchitic patient the increase in Pao2 was brought about by a rise in the ventilation of lung units with a low ventilation:perfusion (V/Q) ratio. It was subsequently confirmed22 by the multiple inert gas infusion technique that in such patients there is considerable blood flow to units with a very low V/Q ratio (0-03-0-01); arterial Po2 would be sensitive to changes in the ventilation of such units.
In emphysema, however, the position is very different. 22 There is substantial ventilation of units with a high V/Q ratio, but no evidence of the low V/Q units found in the group B patients. It could be argued that low V/Q units, or even a true shunt, could come into being with heavy exercise in emphysema; but it seems more likely that diffusion limitations will begin to play a part. In emphysema the destruction of the lung parenchyma brings about an enlargement in the terminal air spaces (and thus a longer diffusion path), a reduction in the surface area of the alveolar-capillary membrane, and a reduction in the pulmonary capillary volume. The last of these changes would lead to a reduction in the transit time of blood through the capillary and this effect would be greater with increase of pulmonary blood flow. If transit time is severely reduced, the oxygen tension of the pulmonary capillary blood will not have time to reach equilibrium with alveolar gas. It has been calculated23 that a fourfold reduction in diffusing capacity would be required to produce a significant fall in Pao2 by this mechanism. The steady fall in tcPo2 with increasing work load seen in most of our more severely affected patients appears to be consistent with the hypothesis that exercise induced hypoxaemia is at least partly due to diffusion limitation associated with a reduced transit time; an increase in the dispersion of transit times would further reduce Pao2.
The onset of relative alveolar hypoventilation during exercise might also account in part for a reduction in Pao2, but we were not able to measure Paco2 in this study. In previous studies,' 182021 however, a rise in Paco2 during exercise occurred in relatively few emphysematous patients and hypoventilation is therefore not likely to be an important contributor to the fall in Pao2.
Administration of bronchodilator aerosols to emphysematous patients has been shown24 to produce a moderate increase in 12 minute walking distance, although it may fail to improve maximal exercise tolerance during a progressive test on a cycle ergometer. 4 In the present study only three of the 10 patients (table 4) achieved a greater work load after fenoterol than after placebo. The average resting tcPo2 after fenoterol was 5.3 mm Hg greater than after placebo (p < 0.02) and 4*2 mm Hg greater than placebo after exercise (p < 0-005). Owing to unavoidable limitations on the study protocol, fenoterol was always administered after placebo, though the nature of the aerosols was not known to 430 the patients. The precise reasons for the observed increases in tcPo2 after fenoterol are therefore not known but could include improved ventilationperfusion relationships or an effect of the first postexercise rise. Electrode drift is another possibility but this was never more than 5 % over the whole study period. The fact remains that, despite the appreciable increase in VC, the results taken overall showed no difference between AtcPo2 values after fenoterol and after placebo, although the two patients (B3 and B4) who had the greatest fall in tcPo2 after placebo showed a much reduced fall after fenoterol. We have no evidence about the reproducibility of exercise induced changes in tcPo2 and further work is required to determine whether large falls in tcPo2 can consistently be modified by bronchodilator treatment.
Calibration of the transcutaneous P02 electrode using atmospheric air has proved satisfactory in newborn infants8 but is less precise in adults,9 presumably owing to unpredictable variations in the thickness and metabolism of the skin and the state of the local circulation. The "in vivo" calibration method'0 used in the present study circumvents some of these sources of variation and an accurate estimate of Pao2 can be obtained by this means. We have shown that a transcutaneous electrode can reflect the blood gas changes taking place during a single progressive exercise test with reasonable accuracy (fig 1) . The performance of the electrode would be acceptable for clinical purposes.
At the end of the exercise period (figs 2 and 3) tcPo2 underwent a rapid increase in all but one patient. To avoid arterial cannulation, the blood gas response to an exercise test is quite commonly assessed by means of a single arterial puncture after the end of the exercise, but our results show that if there is any delay in obtaining the blood sample the lowest Pao2 value will almost certainly be missed and the test invalidated. A similar conclusion was reached by Ries et al,25 who measured Pao2 via an indwelling cannula in some patients with chronic airflow obstruction; in most they observed a rapid rise in Pao2 immediately after the end of exercise. The sudden reduction of metabolic demand and the resulting rise in central venous P02, coupled with persisting ventilatory stimulation, are factors which presumably contribute to the rapid postexercise increase in Pao2.
Any changes in skin blood flow occurring during exercise could theoretically influence tcPo2, but the close correspondence between tcPo2 and Pao2 observed in the type of patient illustrated in figure 1 suggests that this effect is not of great importance. The operating electrode temperature of 45°C presumably ensures maximal vasodilatation in the adjaHughes, Gray, Hutchison cent skin. This method seems preferable to derivation of Pao2 from measurement of oxygen saturation by ear oximetry, as this would require simultaneous estimation of arterial pH and would have an unacceptable error at higher levels of oxygen saturation. 26 We conclude that the transcutaneous P02 electrode can provide a valid estimate of Po2 during exercise in emphysematous patients. It seems likely that this would hold good in normal subjects and patients with other disorders, provided that no undue vasoconstriction took place.9
